Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare TSE:ABX NASDAQ:ACAD NYSE:AIZ NASDAQ:SFIX NASDAQ:TACO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABXBarrick GoldC$39.71-0.7%C$33.38C$21.73▼C$41.24C$67.75B0.7227013.94 million shs5.44 million shsACADACADIA Pharmaceuticals$23.96-2.9%$24.13$13.40▼$26.65$4.16B0.751.82 million shs2.04 million shsAIZAssurant$205.39-1.5%$202.10$174.97▼$230.55$10.52B0.55355,136 shs331,705 shsSFIXStitch Fix$5.48-1.6%$5.00$2.21▼$6.99$726.81M2.032.05 million shs1.80 million shsTACOBerto Acquisition$10.22-0.1%$12.50$7.34▼$12.56$333.43MN/A144,256 shs31,626 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABXBarrick Gold-0.55%-0.17%+20.08%+37.27%+42.91%ACADACADIA Pharmaceuticals+4.49%-2.84%-2.61%+8.20%+51.16%AIZAssurant-2.19%-1.63%-2.09%+5.12%+8.38%SFIXStitch Fix+1.83%-2.28%+12.98%+43.93%+42.09%TACOBerto Acquisition0.00%-0.78%-1.25%-1.25%-18.23%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABXBarrick GoldC$39.71-0.7%C$33.38C$21.73▼C$41.24C$67.75B0.7227013.94 million shs5.44 million shsACADACADIA Pharmaceuticals$23.96-2.9%$24.13$13.40▼$26.65$4.16B0.751.82 million shs2.04 million shsAIZAssurant$205.39-1.5%$202.10$174.97▼$230.55$10.52B0.55355,136 shs331,705 shsSFIXStitch Fix$5.48-1.6%$5.00$2.21▼$6.99$726.81M2.032.05 million shs1.80 million shsTACOBerto Acquisition$10.22-0.1%$12.50$7.34▼$12.56$333.43MN/A144,256 shs31,626 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABXBarrick Gold-0.55%-0.17%+20.08%+37.27%+42.91%ACADACADIA Pharmaceuticals+4.49%-2.84%-2.61%+8.20%+51.16%AIZAssurant-2.19%-1.63%-2.09%+5.12%+8.38%SFIXStitch Fix+1.83%-2.28%+12.98%+43.93%+42.09%TACOBerto Acquisition0.00%-0.78%-1.25%-1.25%-18.23%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABXBarrick Gold 2.92Moderate BuyC$33.63-15.32% DownsideACADACADIA Pharmaceuticals 2.65Moderate Buy$29.6523.74% UpsideAIZAssurant 2.90Moderate Buy$233.2913.58% UpsideSFIXStitch Fix 2.20Hold$5.673.41% UpsideTACOBerto Acquisition 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ABX, AIZ, ACAD, SFIX, and TACO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/12/2025ABXBarrick GoldBMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetC$31.00 ➝ C$37.009/11/2025ACADACADIA PharmaceuticalsCowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy9/11/2025ACADACADIA PharmaceuticalsTD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$35.00 ➝ $39.009/9/2025ACADACADIA PharmaceuticalsUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$36.00 ➝ $39.008/19/2025AIZAssurantZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy8/18/2025AIZAssurantMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingCautious8/18/2025AIZAssurantMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$218.00 ➝ $230.008/12/2025AIZAssurantStephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight8/12/2025AIZAssurantBenchmarkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy8/12/2025AIZAssurantBMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$238.008/12/2025ABXBarrick GoldCibc World MktsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy(Data available from 9/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABXBarrick GoldC$13.82B4.90C$5.49 per share7.23C$18.67 per share2.13ACADACADIA Pharmaceuticals$957.80M4.22$0.68 per share35.00$4.40 per share5.45AIZAssurant$11.88B0.87$21.09 per share9.74$99.57 per share2.06SFIXStitch Fix$1.34B0.53N/AN/A$1.47 per share3.73TACOBerto AcquisitionN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABXBarrick GoldC$1.12BC$1.5924.97∞2.3413.19%6.90%4.00%N/AACADACADIA Pharmaceuticals$226.45M$1.3318.0231.536.2521.80%14.69%9.41%11/5/2025 (Estimated)AIZAssurant$760.20M$13.8114.8710.74N/A5.83%16.47%2.47%11/4/2025 (Estimated)SFIXStitch Fix-$128.84M-$0.46N/AN/AN/A-4.44%-18.15%-7.21%9/23/2025 (Estimated)TACOBerto AcquisitionN/A$0.530.0018.58N/AN/AN/AN/AN/ALatest ABX, AIZ, ACAD, SFIX, and TACO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails9/23/2025Q4 2025SFIXStitch Fix-$0.13N/AN/AN/AN/AN/A8/6/2025Q2 2025ACADACADIA Pharmaceuticals$0.14$0.16+$0.02$0.16$263.07 million$264.57 million8/5/2025Q2 2025AIZAssurant$4.43$5.56+$1.13$4.56$3.13 billion$3.16 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABXBarrick GoldC$0.401.01%N/A25.16%N/AACADACADIA PharmaceuticalsN/AN/AN/AN/AN/AAIZAssurant$3.201.56%N/A23.17%21 YearsSFIXStitch FixN/AN/AN/AN/AN/ATACOBerto AcquisitionN/AN/AN/AN/AN/ALatest ABX, AIZ, ACAD, SFIX, and TACO DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/14/2025AIZAssurantquarterly$0.801.49%9/2/20259/2/20259/29/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABXBarrick Gold19.832.652.62ACADACADIA PharmaceuticalsN/A2.912.83AIZAssurant0.380.400.40SFIXStitch FixN/A1.801.25TACOBerto AcquisitionN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABXBarrick Gold52.76%ACADACADIA Pharmaceuticals96.71%AIZAssurant92.65%SFIXStitch Fix71.04%TACOBerto AcquisitionN/AInsider OwnershipCompanyInsider OwnershipABXBarrick Gold0.60%ACADACADIA Pharmaceuticals28.30%AIZAssurant0.51%SFIXStitch Fix16.95%TACOBerto AcquisitionN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABXBarrick Gold21,3001.71 billionN/ANot OptionableACADACADIA Pharmaceuticals510168.71 million120.97 millionOptionableAIZAssurant14,20050.46 million50.20 millionOptionableSFIXStitch Fix4,570130.49 million108.37 millionOptionableTACOBerto Acquisition7,89232.62 millionN/ANo DataABX, AIZ, ACAD, SFIX, and TACO HeadlinesRecent News About These CompaniesWith 60% ownership, Berto Acquisition Corp. (NASDAQ:TACO) boasts of strong institutional backingAugust 17, 2025 | finance.yahoo.comHow One California Taco Shop Grew Into A Multistate PhenomenonAugust 1, 2025 | msn.comDid Trump just TACO on China? Nvidia's stock and China ADRs are flashing a signal.July 15, 2025 | marketwatch.comBerto Acquisition Corp. (TACO)July 1, 2025 | ca.finance.yahoo.comBerto Acquisition CorpJune 24, 2025 | money.usnews.comPopular California-based taco chain signs deal to open 5 restaurants in LouisvilleJune 15, 2025 | wdrb.comWDel Taco Signs Five-Unit Franchise Agreement in Louisville, KentuckyJune 13, 2025 | shoppingcenterbusiness.comSDel Taco to enter Louisville market with 5-store development agreementJune 13, 2025 | bizjournals.comDel Taco expands to Louisville with new franchise agreementJune 12, 2025 | finance.yahoo.comDel Taco Announces Five-Store Development Agreement in Louisville, KentuckyJune 11, 2025 | businesswire.comIs it time to invest in the real TACO trade? Mexican restaurants now outsell pizza places.June 4, 2025 | msn.comAmerica's 2 biggest taco chains have roots in this little-known Calif. spotJune 4, 2025 | msn.comTaco Bell vs Del Taco - Blind Guy Taste Test #shortsJune 3, 2025 | msn.com7 New Taco Chains You’ll See Everywhere This YearJune 1, 2025 | eatthis.comEBest of Staten Island 2025 results: Here are the top 3 tacos spots as chosen by our readersMay 27, 2025 | silive.comSJack in the Box and Del Taco say they're eyeing expansion in the Columbus areaMay 23, 2025 | msn.com‘Thanks for 20 years’: Chain’s first Idaho restaurant closes in BoiseMay 23, 2025 | msn.comDel Taco launches three new El Big Boxes in USMay 23, 2025 | msn.comPopular Idaho Chain Restaurant Has Closed After 20 YearsMay 23, 2025 | msn.comDel Taco launches brand refresh, boxesMay 21, 2025 | qsrweb.comQNew MarketBeat Followers Over TimeMedia Sentiment Over TimeABX, AIZ, ACAD, SFIX, and TACO Company DescriptionsBarrick Gold TSE:ABXC$39.71 -0.29 (-0.73%) As of 04:26 PM EasternBarrick Gold Corp is one of the world's largest gold producers, operating mines in North America, South America, Australia, and Africa. The company segments consist of nine gold mines namely Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, and Bulyanhulu. It generates maximum revenue from the Carlin mine segment. Geographically, it derives a majority of revenue from the United States.ACADIA Pharmaceuticals NASDAQ:ACAD$23.96 -0.71 (-2.88%) Closing price 04:00 PM EasternExtended Trading$24.46 +0.50 (+2.09%) As of 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization innovative medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases in the United States. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; and DAYBUE, a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 for treatment of Rett Syndrome. It also develops Pimavanserin that is in Phase III ADVANCE-2 study to treat the negative symptoms of schizophrenia; ACP-101 whixh is in Phase III for the treatment of hyperphagia in Prader-Willi syndrome; ACP-204 which is in Phase II for the treatment of Alzheimer's disease psychosis; ACP-2591 that is in Phase I for Rett syndrome and Fragile X syndrome; preclinical antisense oligonucleotide programs; and other programs for neuropsychiatric symptoms. It has a license agreement with Neuren Pharmaceuticals Limited to develop and commercialize trofinetide for Rett syndrome and other indications; and a license and collaboration agreement with Stoke Therapeutics, Inc. to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the CNS. The company was formerly known as Receptor Technologies, Inc. and changed its name ACADIA Pharmaceuticals Inc. in 1997. ACADIA Pharmaceuticals Inc. was incorporated in 1993 and is headquartered in San Diego, California.Assurant NYSE:AIZ$205.39 -3.10 (-1.49%) Closing price 03:59 PM EasternExtended Trading$206.46 +1.07 (+0.52%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Assurant, Inc., together with its subsidiaries, provides business services that supports, protects, and connects consumer purchases in North America, Latin America, Europe, and the Asia Pacific. The company operates through two segments: Global Lifestyle and Global Housing. The Global Lifestyle segment offers mobile device solutions, and extended service contracts and related services for consumer electronics and appliances, and credit and other insurance products; and vehicle protection, commercial equipment, and other related services. The Global Housing segment provides lender-placed homeowners, manufactured housing, and flood insurance; renters insurance and related products; and voluntary manufactured housing, and condominium and homeowners insurance products. The company was formerly known as Fortis, Inc. and changed its name to Assurant, Inc. in February 2004. Assurant, Inc. was founded in 1892 and is headquartered in Atlanta, Georgia.Stitch Fix NASDAQ:SFIX$5.48 -0.09 (-1.62%) Closing price 04:00 PM EasternExtended Trading$5.42 -0.07 (-1.19%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Stitch Fix, Inc. sells a range of apparel, shoes, and accessories for men, women, and kids through its website and mobile application in the United States and the United Kingdom. It offers denim, dresses, blouses, skirts, shoes, jewelry, and handbags under the Stitch Fix brand. The company was formerly known as rack habit inc. and changed its name to Stitch Fix, Inc. in October 2011. Stitch Fix, Inc. was incorporated in 2011 and is headquartered in San Francisco, California.Berto Acquisition NASDAQ:TACODel Taco Restaurants, Inc. develops, franchises, owns, and operates Del Taco quick-service Mexican-American restaurants in the United States. The company's restaurants offer Mexican inspired and American classic dishes. As of August 31, 2021, it operated approximately 600 restaurants across 16 states. The company was founded in 1964 and is headquartered in Lake Forest, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Resideo Technologies: Institutional Activity Signals 30% Upside Lululemon’s Sell-Off Looks Overdone: A Contrarian Case Palantir’s Commercial Growth Story Is Just Getting Started How Bath & Body Works Is a Perfect Example of a Value Stock The Applied Digital Breakout Is Only the Beginning $100 Million Buyback in Upwork Stock Follows a Strong Quarter Uranium Energy Stock Has Momentum—and More Upside Ahead Why Opendoor Stock Is Soaring—and May Just Be Starting Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
